guanethidine has been researched along with Eye Diseases in 16 studies
Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.
Eye Diseases: Diseases affecting the eye.
Excerpt | Relevance | Reference |
---|---|---|
"1% noradrenaline or 10% phenylepherine to either a surgically sympathectomised or a guanethidine treated rabbit eye induced a transient increase in intraocular pressure (IOP), between 90 and 150 min, followed by a fall to hypotensive levels." | 3.66 | Prostaglandin mediated inflammatory changes induced by alpha-adrenoceptor stimulation in the sympathectomised rabbit eye. ( Unger, WG, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BONOMI, L | 2 |
DI COMITE, P | 1 |
UENO, K | 1 |
TUJI, K | 1 |
FUKUDA, H | 1 |
DIOTALLEVI, M | 1 |
TIBERI, GF | 1 |
PANNARALE, C | 1 |
RAGNETTI, E | 1 |
OOSTERHUIS, JA | 1 |
Unger, WG | 1 |
Pasik, T | 1 |
Pasik, P | 1 |
Freis, ED | 1 |
Crombie, AL | 1 |
Lawson, AA | 1 |
Aviner, Z | 1 |
Bonnet, M | 1 |
Lemarchands, H | 1 |
Martin, J | 1 |
Skinner, SW | 1 |
Miller, JE | 1 |
Sneddon, JM | 1 |
Turner, P | 1 |
Gay, AJ | 1 |
Wolkstein, MA | 1 |
1 review available for guanethidine and Eye Diseases
Article | Year |
---|---|
Effectiveness of drug therapy in hypertension: present status. A review.
Topics: Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Eye Diseases; Ganglionic Block | 1971 |
1 trial available for guanethidine and Eye Diseases
Article | Year |
---|---|
Adrenergic blocking agents. A double-blind trial in the treatment of the eye signs of thyroid disorders.
Topics: Antihypertensive Agents; Bretylium Compounds; Clinical Trials as Topic; Edema; Exophthalmos; Eye Dis | 1968 |
14 other studies available for guanethidine and Eye Diseases
Article | Year |
---|---|
[Action of guanethidine on intraocular pressure].
Topics: Eye Diseases; Glaucoma; Guanethidine; Intraocular Pressure; Tetrahymenina; Tonometry, Ocular | 1963 |
[Trial use of a drug to reduce intraocular pressure, 10 per cent Ismelin, as eye drops].
Topics: Eye Diseases; Glaucoma; Guanethidine; Humans; Intraocular Pressure; Ophthalmic Solutions; Tetrahymen | 1963 |
[EFFECTS OF GUANETHIDINE ON OCULAR FLUID DYNAMICS].
Topics: Eye; Eye Diseases; Glaucoma; Guanethidine; Humans; Hydrodynamics; Intraocular Pressure; Tonometry, O | 1963 |
[ON THE EFFECTS OF THE ASSOCIATION OF PILOCARPINE AND GUANETHIDINE INTRAOCULAR TENSION].
Topics: Eye Diseases; Glaucoma; Guanethidine; Humans; Hydrophthalmos; Intraocular Pressure; Pharmacology; Pi | 1963 |
[ON ACTION OF INSTILLATION OF GUANETHIDINE ON EXPERIMENTAL OCULAR HYPERTENSION IN THE RABBIT].
Topics: Animals; Eye Diseases; Guanethidine; Intraocular Pressure; Lagomorpha; Ocular Hypertension; Pharmaco | 1964 |
Guanethidine (Ismelin) in ophthalmology. I. Observations in rabbits.
Topics: Amidines; Animals; Eye Diseases; Guanethidine; Intraocular Pressure; Ophthalmology; Pupil; Rabbits; | 1962 |
Prostaglandin mediated inflammatory changes induced by alpha-adrenoceptor stimulation in the sympathectomised rabbit eye.
Topics: Animals; Epinephrine; Eye; Eye Diseases; Female; Guanethidine; Indomethacin; Intraocular Pressure; M | 1979 |
Experimental models of oculomotor dysfunction in the rhesus monkey.
Topics: Adrenergic alpha-Antagonists; Animals; Corpus Callosum; Disease Models, Animal; Eye Diseases; Eye Mo | 1975 |
Pupil-block. Its mechanism and prevention. II. Dilating the pupil by a mydriaticum-ismelin combination. A procedure with minimal risk.
Topics: Dilatation; Eye Diseases; Glaucoma; Guanethidine; Humans; Intraocular Pressure; Mydriatics; Pupil; S | 1971 |
Guanethidine eyedrops.
Topics: Eye Diseases; Guanethidine; Humans; Ophthalmic Solutions | 1969 |
[Prevention and treatment of the "irreducible mydriasis--progressive atrophy of the iris" syndrome following perforating keratoplasty for keratoconus].
Topics: Acetylcholine; Anesthetics, Local; Atrophy; Atropine; Eye Diseases; Eye Injuries; Guanethidine; Huma | 1969 |
Permanent improvement of thyroid-related upper eyelid retraction from bethanidine.
Topics: Antihypertensive Agents; Cornea; Eye Diseases; Eyelids; Follow-Up Studies; Guanethidine; Guanidines; | 1969 |
The interactions of local guanethidine and sympathomimetic amines in the human eye.
Topics: Amphetamine; Drug Synergism; Ephedrine; Epinephrine; Eye Diseases; Eyelids; Guanethidine; Humans; Hy | 1969 |
Topical guanethidine therapy for endocrine lid retraction.
Topics: Eye Diseases; Eyelids; Graves Disease; Guanethidine; Humans | 1966 |